GlaxoSmithKline Consumer Nigeria Plc released its unaudited financial results for the period ended 30th June, 2021.
- Revenue for the period was N9.9 billion (-5.46% YoY)
- Cost of sales was N7.09 billion. (-7.5% YoY)
- Administrative expenses totalled N1.01 billion. (+13.3% YoY)
- Profit after tax for the period was N59.91 million. (-80.3% YoY)
- Earnings per share of 5 kobo Vs 25 kobo YoY.
See link to results.
